Ying K. Tam - Concepedia

Author

Ying K. Tam

Acuitas Therapeutics (Canada)ORCID

Also Known As

Chatterjee, Debotri, Josh Zaifman, Y. K. Tam, Y.K. Tam, Ying K. Tam, Ying K Tam, Ying K. Tam, Ying Kee Tam, Ying Tam

184

Publications

19.9K

Citations

H-Index

138

Concepts

All Affiliations

Acuitas Therapeutics (Canada)University of Pennsylvania University of British Columbia Duke University Children's Hospital of Philadelphia

About

Ying K. Tam is an author at Acuitas Therapeutics (Canada) specializing in medicine, immunology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	44	9.7K
2	Engineering	16	17	5.5K
3	Natural Sciences	5	5	1.2K
4	Health Sciences	2	2	283
5	Social Sciences	1	1	55

Ying K. Tam

Publications

19.2K

Citations

H-Index

Page 1

	Year	Citations
Rational design of cationic lipids for siRNA delivery Sean C. Semple, Akin Akinc, Jianxin Chen, Nature Biotechnology Lipid PreparationNanomedicineEngineeringRational DesignGene Delivery	2010	1.7K
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs Akin Akinc, Martin A. Maier, Muthiah Manoharan, Nature Nanotechnology NanomedicineEngineeringClinical TranslationMedicineTheranostics	2019	1.5K
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** Muthusamy Jayaraman, Steven M. Ansell, Barbara L. Mui, Angewandte Chemie International Edition	2012	1.2K
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu, Journal of Controlled Release NanotherapeuticsBiochemistryNatural SciencesLipid NanoparticlesMolecular Biology	2015	980
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc, Nature VaccinationVaccinologyVaccine DevelopmentVaccine TargetZika Virus Protection	2017	872
In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates Kiran Musunuru, Alexandra C. Chadwick, Taiji Mizoguchi, Nature Knockout MouseGeneticsGenetic EngineeringGenome EngineeringGenome Editing	2021	713
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses Mohamad‐Gabriel Alameh, István Tombácz, Emily Bettini, Immunity VaccinationNanomedicineCross-protectionMucosal VaccinationVaccine Development	2021	659
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA Nathan M. Belliveau, Jens Huft, Paulo J.C. Lin, Molecular Therapy — Nucleic Acids NanoparticlesNanotherapeuticsEngineeringLipid NanoparticlesGene Delivery	2012	646
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics Martin A. Maier, Muthusamy Jayaraman, Shigeo Matsuda, Molecular Therapy	2013	594
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses Norbert Pardi, Michael J. Hogan, Martin S. Naradikian, The Journal of Experimental Medicine	2018	501

Page 1